About 250 mg Abirite Abiraterone Acetate Tablets
Experience a gilt-edged deal with Abirite-250, elite 250 mg Abiraterone Acetate Tablets from Samarth Life Sciences Pvt. Ltd. Specially crafted for men diagnosed with metastatic castration-resistant prostate cancer, these tablets boast unmatched purity and are manufactured under stringent GMP guidelines. Get this ravishing solution, supplied in a bottle of 120 tablets, each offering precise 250 mg dosage. Customizable supply options are available for exporters, manufacturers, suppliers, and traders across India. To be used under strict medical supervision. Store in original container, shielded from light and moisture for optimum efficacy. Prescription required.
Elite Application and Features
Abirite-250 Abiraterone Acetate Tablets are tailored for oncology applications, specifically for advanced prostate cancer treatment. Comprised of high-purity Abiraterone Acetate and other excipients, each tablet is white to off-white and is administered orally. Key features include GMP manufacturing standards, protection from moisture and light, and suitability for global supply chains. These tablets serve leading medical facilities, specialized oncology centers, and export markets, ensuring reliable performance in all clinical settings.
Export Market Edge and Transaction Terms
Our ravishing product, Abirite-250, is regularly handed over to elite markets in Asia, Africa, and Latin America. Quotation for export orders is promptly given, ensuring transparency and efficiency. Goods transport is streamlined for both bulk and small shipments, with payment terms including advance, Telegraphic Transfer, and Letter of Credit accepted. Samples for evaluation are available upon request, promoting confidence in quality before large-scale purchase.
FAQ's of 250 mg Abirite Abiraterone Acetate Tablets:
Q: How should Abirite-250 Abiraterone Acetate Tablets be stored?
A: Abirite-250 tablets should be stored below 30C, in a tightly closed container, and protected from moisture and light to maintain their potency.
Q: What is the primary benefit of using Abirite-250 for patients?
A: Abirite-250 is designed for men with metastatic castration-resistant prostate cancer, providing an effective treatment option to manage and suppress cancer progression.
Q: Where is Abirite-250 primarily exported and supplied?
A: Abirite-250 is exported and supplied to elite markets across Asia, Africa, and Latin America, serving healthcare providers and oncology specialists.
Q: What payment options are available for procuring Abirite-250 tablets?
A: Payment terms include advance payment, telegraphic transfer, and letter of credit, ensuring a flexible and secure transaction process for all clients.
Q: How is the sample procurement process handled for new clients?
A: Samples of Abirite-250 can be requested and will be handed over for evaluation to ensure product quality before confirming any bulk order or larger quotation.